Cendakimab (Anti–IL-13) administration improves esophageal gene expression in eosinophilic esophagitis

Journal:

The Journal of Allergy and Clinical Immunology

Published:

2025-10-10

DOI:

10.1016/j.jaci.2025.08.032

Affiliations:

5

Authors:

7

Go to article

Institutions	Authors	Share
Cincinnati Children's Hospital Medical Center (CCHMC), United States of America (USA)	3.000000	0.43
Bristol-Myers Squibb, United States of America (USA)	3.000000	0.43
The University of North Carolina at Chapel Hill (UNC), United States of America (USA)	1.000000	0.14

Interested in Cardiovascular Medicine and Haematology?